Metadata
| Source Table | grants |
| Source ID | THQJmrLMYh |
| Description | to Eradivir, USD 1000000, 2023-07 |
| Source URL | coefficientgiving.org/funds/ |
| Parent | Coefficient Giving |
| Children | — |
| Created | Mar 12, 2026, 5:54 AM |
| Updated | Mar 22, 2026, 2:59 AM |
| Synced | Mar 19, 2026, 8:57 PM |
Record Data
id | THQJmrLMYh |
organizationId | Coefficient Giving(organization) |
granteeId | Eradivir |
orgEntityId | Coefficient Giving(organization) |
orgDisplayName | — |
granteeEntityId | — |
granteeDisplayName | Eradivir |
name | Eradivir — Influenza Antiviral Drug |
amount | 1000000 |
currency | USD |
period | — |
date | 2023-07 |
status | — |
source | coefficientgiving.org/funds/ |
notes | [Biosecurity & Pandemic Preparedness] Open Philanthropy recommended an investment of $1,000,000 in Eradivir to support the development of an influenza antiviral drug. The team’s novel antiviral approach links two haptens that recruit the immune system to an already approved influenza antiviral, zana… |
programId | IVKWfIkgOz |
dataSourceId | — |
Source Check Verdicts
confirmed95% confidence
Last checked: 4/9/2026
[deterministic-row-match] Deterministic match: grantee, amount, date matched in source snapshot (2714 rows)
Debug info
Thing ID: THQJmrLMYh
Source Table: grants
Source ID: THQJmrLMYh
Parent Thing ID: sid_ULjDXpSLCI